Baudax Bio, Inc. is a pharmaceutical company that specializes in creating innovative products for hospitals and acute care facilities. Their main product, ANJESO (meloxicam) injection, is used to manage moderate to severe pain and can be combined with non-NSAID analgesics. They also have several products under development, including BX1000, BX2000, BX3000, and Dex-IN, all of which are either in phase I or II clinical trials.